APA (7th ed.) Citation

CK, C., RA, K., P, M., MS, K., EJ, M., C, P., . . . UJ, B. (2022). Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children. The Journal of infectious diseases, 226(12), 2069. https://doi.org/10.1093/infdis/jiac253

Chicago Style (17th ed.) Citation

CK, Cunningham, et al. "Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children." The Journal of Infectious Diseases 226, no. 12 (2022): 2069. https://doi.org/10.1093/infdis/jiac253.

MLA (9th ed.) Citation

CK, Cunningham, et al. "Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children." The Journal of Infectious Diseases, vol. 226, no. 12, 2022, p. 2069, https://doi.org/10.1093/infdis/jiac253.